Table 1.

Demographic and clinical characteristics of patients prescribed any UC medication [Objective A-1]

Year	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016
Patients prescribed UC medicationsa, n	121	146	168	278	501	945	1594	2346	3977	4534	6215
Sex, male, n [%]	76 [62.8]	98 [67.1]	111 [66.1]	187 [67.3]	309 [61.7]	604 [63.9]	1034 [64.9]	1547 [65.9]	2597 [65.3]	2927 [64.6]	3973 [63.9]
Age, years, median [IQR]	40.0 [33.0, 47.0]	39.0 [33.0, 46.5]	39.0 [33.0, 45.0]	39.0 [32.3, 46.0]	40.0 [32.0, 47.0]	41.0 [33.0, 48.0]	42.0 [34.0, 49.0]	42.0 [35.0, 50.0]	43.0 [35.0, 51.0]	43.0 [35.0, 51.0]	44.0 [36.0, 52.0]
Medical institution visited during the follow up period, n [%]
University hospital	19 [15.7]	18 [12.3]	19 [11.3]	44 [15.8]	85 [17.0]	143 [15.1]	219 [13.7]	346 [14.7]	543 [13.7]	603 [13.3]	952 [15.3]
National/public hospital	31 [25.6]	31 [21.2]	30 [17.9]	52 [18.7]	79 [15.8]	128 [13.5]	228 [14.3]	308 [13.1]	529 [13.3]	602 [13.3]	807 [13.0]
Clinic [<20 beds]	33 [27.3]	47 [32.2]	60 [35.7]	98 [35.3]	186 [37.1]	337 [35.7]	555 [34.8]	846 [36.1]	1460 [36.7]	1729 [38.1]	2358 [37.9]
Other hospitalb	43 [35.5]	61 [41.8]	70 [41.7]	103 [37.1]	178 [35.5]	377 [39.9]	687 [43.1]	978 [41.7]	1670 [42.0]	1861 [41.0]	2445 [39.3]
Unknown	4 [3.3]	4 [2.7]	4 [2.4]	1 [0.4]	0	0	0	3 [0.1]	1 [0.0]	2 [0.0]	2 [0.0]

Abbreviations: 5-ASA, 5-aminosalicylic acid; CS, corticosteroid; IQR, interquartile range; PSL, prednisolone; UC, ulcerative colitis.

^aThe following UC medications were included in the analysis: 5-ASA (salazosulfapyridine [oral, suppository], mesalazine [oral, suppository, enema]), CS (PSL [oral], PSL sodium succinate [injection]), thiopurine (azathioprine [oral], mercaptopurine hydrate [oral]), biologics [infliximab, adalimumab, golimumab, vedolizumab] and others (tofacitinib citrate [oral], tacrolimus hydrate [oral]).

^bHospital with ≥20 beds other than a university hospital or national/public hospital.